XPhyto Therapeutics to Present at Munich Investment Conference 08 and 09 November 2019
ACCESS Newswire
05 Nov 2019, 23:14 GMT+10
VANCOUVER, BC / ACCESSWIRE / November 5, 2019 / XPhyto Therapeutics Corp. (CSE:XPHY)(FSE:4XT) ('XPhyto' or the 'Company') is pleased to announce that it will be presenting at the International Precious Metals & Commodities Show Munich on November 8th and 9th, 2019. The Company will have a booth on the conference floor and will be presenting to the audience on the entrance stage on Friday, November 8, 2019 at 4:50 PM.
XPhyto is a European focused cannabis company with German operations and the only cannabis company presenting at the Munich investment conference. The Company welcomes all those interested in XPhyto to visit the booth and meet the team.
About XPhyto Therapeutics Corp.
XPhyto is a next-generation cannabis company focused on formulation, clinical validation, and emerging European markets. XPhyto's 100% owned German subsidiary, Bunker Pflanzenextrakte GmbH, has been granted a unique German cannabis cultivation and extraction licence for scientific purposes by the German Federal Institute for Drugs and Medical Devices (BfArM). Bunker has two exclusive R&D collaboration agreements with the Technical University of Munich, Faculty of Chemistry as well as the Chair of Beverage and Brewing Technology. XPhyto acquired 100% of Vektor Pharma TF GmbH, a German narcotics manufacturer, importer and researcher with expertise in the design, testing and manufacture of thin film drug delivery systems, particularly transdermal patches and sub-lingual (oral) strips for the clinical management of pain. XPhyto is pursuing additional opportunities in Germany including commercial cultivation, processing, manufacturing, import, and distribution. In Canada, two exclusive 5-year engagements with the Faculty of Pharmacy at a major Canadian university provide certified extraction, isolation, and formulation facilities, drug research and development expertise, as well as commercial analytical testing capability.
For further information, please contact:
Hugh Rogers
CEO & Director
+1.780.818.6422
[email protected]
www.xphyto.com
Robert Barth
VP European Corporate Development
+49 8331 99481 10
[email protected]
www.xphyto.com
Forward looking statements
This news release includes statements containing forward-looking information within the meaning of applicable Canadian securities law ('forward-looking statements'). Forward-looking statements are frequently characterized by words such as 'develop', 'plan', 'continue', 'expect', 'project', 'intend', 'believe', 'anticipate', 'estimate', 'potential', 'propose' and other similar words, or statements that certain events or conditions 'may' or 'will' occur, and in this release include the statement regarding the Company's goal of building an industry leading medical cannabis company Forward-looking statements are only predictions based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements, including: that the Company may not derive the expected, or any, benefits from the Licence; that the Company may be unable to scale its business; product liability risks; frequent changes to cannabis regulations in Canada and internationally; general economic conditions; adverse industry events; future legislative and regulatory developments; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; competition; international risks; and other risks beyond the Company's control. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.
Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this news release.
SOURCE: XPhyto Therapeutics Corp.
View source version on accesswire.com:
https://www.accesswire.com/565357/XPhyto-Therapeutics-to-Present-at-Munich-Investment-Conference-08-and-09-November-2019
Share
Tweet
Share
Flip
Email
Subscribe and Follow
Get a daily dose of Vancouver Star news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
News RELEASES
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Vancouver Star.
More InformationIRS begins major layoffs, civil rights office hit first
WASHINGTON, D.C.: The U.S. Internal Revenue Service (IRS) began laying off workers late last week, according to an email sent to staff,...
Civilians and Hostages Face Starvation and Continuous Bombardment
GAZA STRIP - As the conflict in Gaza intensifies, the humanitarian crisis has reached unprecedented levels. The death toll has risen...
Georgia Senate passes bill to ban DEI programs in schools and colleges
ATLANTA, Georgia: Georgia senators ended the 39th day of their 2025 session this week by approving a bill that would ban diversity,...
AlabamIncreasingly, states are attempting to limit or ban the use of phones in schools. Many people worry that phones distract students and that too much screen time and social media can harm mental health.a House moves to ban cellphones in public schools
MONTGOMERY, Alabama: Alabama's House of Representatives has passed a bill that would stop students from using cellphones in public...
Japan’s auto industry at risk from new US tariffs, says UN agency
GENEVA, Switzerland: Japan's car industry is facing a multibillion-dollar blow as sweeping U.S. auto tariffs threaten its largest export...
Ocean Liner to become largest artificial reef in the world off Florida
TALLAHASSEE, Florida: A famous old ocean liner, the SS United States, will soon become the world's biggest artificial reef off the...
Medicare backs off Biden plan for weight-loss drug coverage
WASHINGTON, D.C.: The Centers for Medicare & Medicaid Services (CMS) says it will not go ahead with a plan from the Biden administration...
U.S. stock markets slide again as tariffs on China rise to 104%
NEW YORK, New York - U.S. stocks tumbled again on Tuesday, igniting fear of the fallout from U.S. President's Donald Trump's trade...
Nissan eyes manufacturing shift to dodge US Tariffs
TOKYO, Japan: Nissan may soon make a strategic shift in its manufacturing operations, according to a new report from Japan's Nikkei...
Vegetable oil price surge stabilizes global food costs in March
PARIS, France: A spike in vegetable oil costs helped steady global food prices in March, offsetting declines in other staples like...
Portugal's mega data centre gets multi-billion-euro investment boost
SINES, Portugal: A massive data centre project in Portugal is set to receive a multi-billion-euro boost, as tech giants fuel global...
Dow Jones drops 329 points as stock sell-off continues
NEW YORK, New York - U.S. stocks settled on Monday following massive falls across the globe. Hong Kong's key index, the Hang Seng dived...
